Principal Investigator
Juan Alderuccio
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20260107
Clinical Trial Summary
A Phase 1/2, First-in-Human, Open-Label, Multicenter Study of TORL-5-700 as a Monotherapy and in Combination for Participants with Relapsed or Refractory Non-Hodgkin Lymphoma
Phase
Phase I/II
Funding Agency/Sponsor
Industrial
Disease
Lymphoma
Contact Information
Phone Number
305-243-2647